A recent study in a transgenic mouse model of PD suggests that enhancing GLP‐1 secretion in the enteric nervous system offers central and enteric neuroprotection against synucleinopathy‐induced neurodegeneration (Pradeloux et al. 2024). Here, GCG is linked to Parkinson disease.